MENU

NVRO Stock NVRO is expected to report earnings to rise+41% to -83 cents per share on April 30

A.I.dvisor
at Tickeron.com
Loading...
NVRO - NEVRO Corp
NEVRO Corp Earnings Graph
Q1'25
Est.
$-0.83
Q4'24
Missed
by $0.63
Q3'24
Beat
by $0.40
Q2'24
Beat
by $0.17
Q1'24
Beat
by $0.35
The last earnings report on December 31 showed earnings per share of -141 cents, missing the estimate of -78 cents. P/B Ratio (1.654) is normal, around the industry mean (10.414). P/E Ratio (147.059) is within average values for comparable stocks, (81.243). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (5.667). Dividend Yield (0.000) settles around the average of (0.018) among similar stocks. P/S Ratio (1.127) is also within normal values, averaging (42.332). With 753.60K shares outstanding, the current market capitalization sits at 525.59M.
View a ticker or compare two or three
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a maker of medical devices

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
1800 Bridge Parkway
Phone
+1 650 251-0005
Employees
1215
Web
https://www.nevro.com